• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Metabolism and kinetics of bupropion.

作者信息

Schroeder D H

出版信息

J Clin Psychiatry. 1983 May;44(5 Pt 2):79-81.

PMID:6406469
Abstract

Studies of bupropion in rats, dogs, and normal volunteers showed that bupropion was rapidly and completely absorbed, widely distributed in tissues, and metabolized extensively prior to its excretion. Metabolism in rats and dogs appeared to be predominantly by side chain oxidative cleavage, while reduction of the intact parent aminoketone to an aminoalcohol was an additional major pathway in man. Most of the metabolites were excreted in urine. Bupropion, but not its metabolites, was concentrated in many tissues, with a brain to plasma ratio of about 25:1. Plasma protein binding of bupropion (75%-80%) did not seem to limit its tissue distribution. Bupropion was found to be a weak to moderate inducer of drug metabolism.

摘要

相似文献

1
Metabolism and kinetics of bupropion.
J Clin Psychiatry. 1983 May;44(5 Pt 2):79-81.
2
Pharmacological significance of the species differences in bupropion metabolism.安非他酮代谢物种差异的药理学意义。
Xenobiotica. 1987 Mar;17(3):287-98. doi: 10.3109/00498258709043939.
3
Clinical pharmacokinetics of bupropion: a review.
J Clin Psychiatry. 1983 May;44(5 Pt 2):82-4.
4
Radioimmunoassay and pharmacokinetic profile of bupropion in the dog.犬体内安非他酮的放射免疫分析及药代动力学特征
J Pharmacol Exp Ther. 1981 Jun;217(3):602-10.
5
Pharmacokinetics of bupropion and metabolites in plasma and brain of rats, mice, and guinea pigs.
Drug Metab Dispos. 1986 Nov-Dec;14(6):692-7.
6
Relationship between bupropion disposition and dopamine uptake inhibition in rats and mice.
J Pharmacol Exp Ther. 1982 Jun;221(3):676-85.
7
Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.环氧合酶抑制性一氧化氮供体(CINOD)AZD3582的临床前药代动力学
J Pharm Pharmacol. 2005 May;57(5):587-97. doi: 10.1211/0022357056028.
8
Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.新型类视黄醇4-[(5,6,7,8-四氢-5,5,8,8-四甲基-2-萘基)氨基甲酰基]苯甲酸的代谢与处置研究。第四次通讯:在各种动物和人类中的吸收、代谢、排泄及血浆蛋白结合情况
Arzneimittelforschung. 1997 Mar;47(3):259-69.
9
Disposition of remoxipride in different species. Species differences in metabolism.瑞莫必利在不同物种中的处置。代谢的物种差异。
Arzneimittelforschung. 1993 Mar;43(3):287-97.
10
The effect of H2-antagonists on the absorption of bupropion in rats.H2拮抗剂对大鼠体内安非他酮吸收的影响。
Res Commun Chem Pathol Pharmacol. 1988 Feb;59(2):279-82.

引用本文的文献

1
Bupropion Mediated Effects on Depression, Attention Deficit Hyperactivity Disorder, and Smoking Cessation.安非他酮对抑郁症、注意力缺陷多动障碍及戒烟的介导作用。
Health Psychol Res. 2023 Jul 1;11:81043. doi: 10.52965/001c.81043. eCollection 2023.
2
Stereoselective Metabolism of Bupropion to Active Metabolites in Cellular Fractions of Human Liver and Intestine.人肝和肠细胞组分中布普品对映体选择性代谢为活性代谢物。
Drug Metab Dispos. 2023 Jan;51(1):54-66. doi: 10.1124/dmd.122.000867. Epub 2022 May 5.
3
Bupropion Inhibits Serotonin Type 3AB Heteromeric Channels at Clinically Relevant Concentrations.
安非他酮以临床相关浓度抑制 5-羟色胺 3AB 异源四聚体通道。
Mol Pharmacol. 2020 Mar;97(3):171-179. doi: 10.1124/mol.119.118349. Epub 2019 Dec 23.
4
Transport of Bupropion and its Metabolites by the Model CHO and HEK293 Cell Lines.安非他酮及其代谢物在CHO和HEK293细胞系模型中的转运
Drug Metab Lett. 2019;13(1):25-36. doi: 10.2174/1872312813666181129101507.
5
Evaluation of a Potential Clinical Significant Drug-Drug Interaction between Digoxin and Bupropion in Cynomolgus Monkeys.评价地高辛与安非他酮在食蟹猴体内的潜在临床显著药物-药物相互作用。
Pharm Res. 2018 Nov 6;36(1):1. doi: 10.1007/s11095-018-2525-z.
6
Comparison of In Vitro Stereoselective Metabolism of Bupropion in Human, Monkey, Rat, and Mouse Liver Microsomes.安非他酮在人、猴、大鼠和小鼠肝微粒体中的体外立体选择性代谢比较。
Eur J Drug Metab Pharmacokinet. 2019 Apr;44(2):261-274. doi: 10.1007/s13318-018-0516-4.
7
Prediction of Drug-Drug Interactions with Bupropion and Its Metabolites as CYP2D6 Inhibitors Using a Physiologically-Based Pharmacokinetic Model.使用基于生理的药代动力学模型预测安非他酮及其代谢产物作为CYP2D6抑制剂的药物相互作用
Pharmaceutics. 2017 Dec 21;10(1):1. doi: 10.3390/pharmaceutics10010001.
8
Psychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicity.精神药物与肝脏疾病:药代动力学及肝脏毒性的批判性综述
World J Gastrointest Pharmacol Ther. 2017 Feb 6;8(1):26-38. doi: 10.4292/wjgpt.v8.i1.26.
9
Identification of non-reported bupropion metabolites in human plasma.人血浆中未报告的安非他酮代谢物的鉴定。
Biopharm Drug Dispos. 2016 Dec;37(9):550-560. doi: 10.1002/bdd.2046.
10
The antidepressant bupropion is a negative allosteric modulator of serotonin type 3A receptors.抗抑郁药安非他酮是5-羟色胺3A受体的负性变构调节剂。
Neuropharmacology. 2017 Feb;113(Pt A):89-99. doi: 10.1016/j.neuropharm.2016.09.021. Epub 2016 Sep 24.